fluorodeoxyglucose f18 has been researched along with Altitude Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Z; Ge, RL; Li, Y; Qi, G; Song, K; Wang, S; Yan, R; Yang, Y; Zhang, Y | 1 |
| Buck, A; Hefti, U; Maggiorini, M; Merz, TM; Schwarz, U; Spengler, CM; Treyer, V | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Altitude Hypoxia
| Article | Year |
|---|---|
Changes in cerebral glucose metabolism after an expedition to high altitudes.
Topics: Acute Disease; Adult; Altitude Sickness; Brain; Cerebellum; Expeditions; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mountaineering; Positron-Emission Tomography; Statistics, Nonparametric; Temporal Lobe | 2006 |
1 other study(ies) available for fluorodeoxyglucose f18 and Altitude Hypoxia
| Article | Year |
|---|---|
Adipose-derived exosomal miR-210/92a cluster inhibits adipose browning via the FGFR-1 signaling pathway in high-altitude hypoxia.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Altitude Sickness; Animals; Exosomes; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Hypoxia; Maillard Reaction; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction | 2020 |